nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Dysuria—Temozolomide—brain cancer	0.00318	0.00318	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Carmustine—brain cancer	0.00317	0.00317	CcSEcCtD
Gadoversetamide—Angiopathy—Hydroxyurea—brain cancer	0.00316	0.00316	CcSEcCtD
Gadoversetamide—Pneumonia—Carmustine—brain cancer	0.00315	0.00315	CcSEcCtD
Gadoversetamide—Shock—Procarbazine—brain cancer	0.00314	0.00314	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Procarbazine—brain cancer	0.00313	0.00313	CcSEcCtD
Gadoversetamide—Chills—Hydroxyurea—brain cancer	0.00312	0.00312	CcSEcCtD
Gadoversetamide—Tachycardia—Procarbazine—brain cancer	0.00312	0.00312	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Procarbazine—brain cancer	0.00309	0.00309	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Temozolomide—brain cancer	0.00307	0.00307	CcSEcCtD
Gadoversetamide—Urinary tract infection—Carmustine—brain cancer	0.00305	0.00305	CcSEcCtD
Gadoversetamide—Pneumonia—Temozolomide—brain cancer	0.00305	0.00305	CcSEcCtD
Gadoversetamide—Anorexia—Procarbazine—brain cancer	0.00305	0.00305	CcSEcCtD
Gadoversetamide—Erythema—Hydroxyurea—brain cancer	0.00303	0.00303	CcSEcCtD
Gadoversetamide—Nausea—Lomustine—brain cancer	0.00299	0.00299	CcSEcCtD
Gadoversetamide—Hypotension—Procarbazine—brain cancer	0.00299	0.00299	CcSEcCtD
Gadoversetamide—Urinary tract infection—Temozolomide—brain cancer	0.00295	0.00295	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00291	0.00291	CcSEcCtD
Gadoversetamide—Insomnia—Procarbazine—brain cancer	0.00289	0.00289	CcSEcCtD
Gadoversetamide—Paraesthesia—Procarbazine—brain cancer	0.00287	0.00287	CcSEcCtD
Gadoversetamide—Sinusitis—Temozolomide—brain cancer	0.00284	0.00284	CcSEcCtD
Gadoversetamide—Somnolence—Procarbazine—brain cancer	0.00284	0.00284	CcSEcCtD
Gadoversetamide—Haemoglobin—Carmustine—brain cancer	0.00283	0.00283	CcSEcCtD
Gadoversetamide—Haemorrhage—Carmustine—brain cancer	0.00281	0.00281	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.00281	0.00281	CcSEcCtD
Gadoversetamide—Hallucination—Carmustine—brain cancer	0.0028	0.0028	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Carmustine—brain cancer	0.0028	0.0028	CcSEcCtD
Gadoversetamide—Decreased appetite—Procarbazine—brain cancer	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Etoposide—brain cancer	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Oedema peripheral—Carmustine—brain cancer	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Fatigue—Procarbazine—brain cancer	0.00276	0.00276	CcSEcCtD
Gadoversetamide—Haemoglobin—Temozolomide—brain cancer	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Malaise—Hydroxyurea—brain cancer	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Pain—Procarbazine—brain cancer	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Constipation—Procarbazine—brain cancer	0.00273	0.00273	CcSEcCtD
Gadoversetamide—Haemorrhage—Temozolomide—brain cancer	0.00272	0.00272	CcSEcCtD
Gadoversetamide—Dysphagia—Etoposide—brain cancer	0.00272	0.00272	CcSEcCtD
Gadoversetamide—Hallucination—Temozolomide—brain cancer	0.00271	0.00271	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Temozolomide—brain cancer	0.00271	0.00271	CcSEcCtD
Gadoversetamide—Pharyngitis—Temozolomide—brain cancer	0.0027	0.0027	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Temozolomide—brain cancer	0.00269	0.00269	CcSEcCtD
Gadoversetamide—Oedema peripheral—Temozolomide—brain cancer	0.00268	0.00268	CcSEcCtD
Gadoversetamide—Bronchospasm—Etoposide—brain cancer	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Urethral disorder—Temozolomide—brain cancer	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Sweating increased—Etoposide—brain cancer	0.00265	0.00265	CcSEcCtD
Gadoversetamide—Feeling abnormal—Procarbazine—brain cancer	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Eye disorder—Carmustine—brain cancer	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Convulsion—Hydroxyurea—brain cancer	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Procarbazine—brain cancer	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Flushing—Carmustine—brain cancer	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Erythema multiforme—Temozolomide—brain cancer	0.00257	0.00257	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00256	0.00256	CcSEcCtD
Gadoversetamide—Discomfort—Hydroxyurea—brain cancer	0.00255	0.00255	CcSEcCtD
Gadoversetamide—Eye disorder—Temozolomide—brain cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Urticaria—Procarbazine—brain cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Tinnitus—Temozolomide—brain cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Abdominal pain—Procarbazine—brain cancer	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Body temperature increased—Procarbazine—brain cancer	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Flushing—Temozolomide—brain cancer	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Cardiac disorder—Temozolomide—brain cancer	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Arrhythmia—Carmustine—brain cancer	0.00251	0.00251	CcSEcCtD
Gadoversetamide—Oedema—Hydroxyurea—brain cancer	0.00247	0.00247	CcSEcCtD
Gadoversetamide—Angiopathy—Temozolomide—brain cancer	0.00247	0.00247	CcSEcCtD
Gadoversetamide—Mental disorder—Carmustine—brain cancer	0.00247	0.00247	CcSEcCtD
Gadoversetamide—Immune system disorder—Temozolomide—brain cancer	0.00246	0.00246	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Temozolomide—brain cancer	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Erythema—Carmustine—brain cancer	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Malnutrition—Carmustine—brain cancer	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Chills—Temozolomide—brain cancer	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Pneumonia—Etoposide—brain cancer	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Nervous system disorder—Hydroxyurea—brain cancer	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.00242	0.00242	CcSEcCtD
Gadoversetamide—Skin disorder—Hydroxyurea—brain cancer	0.0024	0.0024	CcSEcCtD
Gadoversetamide—Mental disorder—Temozolomide—brain cancer	0.00238	0.00238	CcSEcCtD
Gadoversetamide—Back pain—Carmustine—brain cancer	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Erythema—Temozolomide—brain cancer	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Malnutrition—Temozolomide—brain cancer	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Anorexia—Hydroxyurea—brain cancer	0.00236	0.00236	CcSEcCtD
Gadoversetamide—Hypersensitivity—Procarbazine—brain cancer	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Dysgeusia—Temozolomide—brain cancer	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Vision blurred—Carmustine—brain cancer	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Tremor—Carmustine—brain cancer	0.0023	0.0023	CcSEcCtD
Gadoversetamide—Asthenia—Procarbazine—brain cancer	0.00229	0.00229	CcSEcCtD
Gadoversetamide—Back pain—Temozolomide—brain cancer	0.00229	0.00229	CcSEcCtD
Gadoversetamide—Pruritus—Procarbazine—brain cancer	0.00226	0.00226	CcSEcCtD
Gadoversetamide—Agitation—Carmustine—brain cancer	0.00225	0.00225	CcSEcCtD
Gadoversetamide—Vision blurred—Temozolomide—brain cancer	0.00223	0.00223	CcSEcCtD
Gadoversetamide—Tremor—Temozolomide—brain cancer	0.00222	0.00222	CcSEcCtD
Gadoversetamide—Dyspnoea—Hydroxyurea—brain cancer	0.00221	0.00221	CcSEcCtD
Gadoversetamide—Somnolence—Hydroxyurea—brain cancer	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Temozolomide—brain cancer	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Diarrhoea—Procarbazine—brain cancer	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Dyspepsia—Hydroxyurea—brain cancer	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Agitation—Temozolomide—brain cancer	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Etoposide—brain cancer	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Decreased appetite—Hydroxyurea—brain cancer	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Etoposide—brain cancer	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Malaise—Temozolomide—brain cancer	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Urethral disorder—Etoposide—brain cancer	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Fatigue—Hydroxyurea—brain cancer	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Vertigo—Temozolomide—brain cancer	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Convulsion—Carmustine—brain cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Hypertension—Carmustine—brain cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Constipation—Hydroxyurea—brain cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Pain—Hydroxyurea—brain cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Dizziness—Procarbazine—brain cancer	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Palpitations—Temozolomide—brain cancer	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Myalgia—Carmustine—brain cancer	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Chest pain—Carmustine—brain cancer	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Anxiety—Carmustine—brain cancer	0.00208	0.00208	CcSEcCtD
Gadoversetamide—Cough—Temozolomide—brain cancer	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Erythema multiforme—Etoposide—brain cancer	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Convulsion—Temozolomide—brain cancer	0.00205	0.00205	CcSEcCtD
Gadoversetamide—Hypertension—Temozolomide—brain cancer	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Feeling abnormal—Hydroxyurea—brain cancer	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Eye disorder—Etoposide—brain cancer	0.00203	0.00203	CcSEcCtD
Gadoversetamide—Vomiting—Procarbazine—brain cancer	0.00203	0.00203	CcSEcCtD
Gadoversetamide—Cardiac disorder—Etoposide—brain cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Flushing—Etoposide—brain cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Confusional state—Carmustine—brain cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Arthralgia—Temozolomide—brain cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Myalgia—Temozolomide—brain cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Rash—Procarbazine—brain cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Dermatitis—Procarbazine—brain cancer	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Anxiety—Temozolomide—brain cancer	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Headache—Procarbazine—brain cancer	0.002	0.002	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.002	0.002	CcSEcCtD
Gadoversetamide—Oedema—Carmustine—brain cancer	0.002	0.002	CcSEcCtD
Gadoversetamide—Discomfort—Temozolomide—brain cancer	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Angiopathy—Etoposide—brain cancer	0.00197	0.00197	CcSEcCtD
Gadoversetamide—Dry mouth—Temozolomide—brain cancer	0.00197	0.00197	CcSEcCtD
Gadoversetamide—Immune system disorder—Etoposide—brain cancer	0.00197	0.00197	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Etoposide—brain cancer	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Carmustine—brain cancer	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Body temperature increased—Hydroxyurea—brain cancer	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Chills—Etoposide—brain cancer	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Tachycardia—Carmustine—brain cancer	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Confusional state—Temozolomide—brain cancer	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Temozolomide—brain cancer	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Oedema—Temozolomide—brain cancer	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Anorexia—Carmustine—brain cancer	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Nausea—Procarbazine—brain cancer	0.0019	0.0019	CcSEcCtD
Gadoversetamide—Nervous system disorder—Temozolomide—brain cancer	0.0019	0.0019	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Temozolomide—brain cancer	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Skin disorder—Temozolomide—brain cancer	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Hypotension—Carmustine—brain cancer	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Temozolomide—brain cancer	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Dysgeusia—Etoposide—brain cancer	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Anorexia—Temozolomide—brain cancer	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Back pain—Etoposide—brain cancer	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Hypersensitivity—Hydroxyurea—brain cancer	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Carmustine—brain cancer	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Muscle spasms—Etoposide—brain cancer	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Insomnia—Carmustine—brain cancer	0.00181	0.00181	CcSEcCtD
Gadoversetamide—Paraesthesia—Carmustine—brain cancer	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Dyspnoea—Carmustine—brain cancer	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Somnolence—Carmustine—brain cancer	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Asthenia—Hydroxyurea—brain cancer	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Etoposide—brain cancer	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Insomnia—Temozolomide—brain cancer	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Decreased appetite—Carmustine—brain cancer	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Paraesthesia—Temozolomide—brain cancer	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Carmustine—brain cancer	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Dyspnoea—Temozolomide—brain cancer	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Somnolence—Temozolomide—brain cancer	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Constipation—Carmustine—brain cancer	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Pain—Carmustine—brain cancer	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Malaise—Etoposide—brain cancer	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Vertigo—Etoposide—brain cancer	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Dyspepsia—Temozolomide—brain cancer	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Diarrhoea—Hydroxyurea—brain cancer	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Decreased appetite—Temozolomide—brain cancer	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Fatigue—Temozolomide—brain cancer	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Loss of consciousness—Etoposide—brain cancer	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Cough—Etoposide—brain cancer	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Pain—Temozolomide—brain cancer	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Constipation—Temozolomide—brain cancer	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Feeling abnormal—Carmustine—brain cancer	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Convulsion—Etoposide—brain cancer	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Hypertension—Etoposide—brain cancer	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Dizziness—Hydroxyurea—brain cancer	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Carmustine—brain cancer	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Chest pain—Etoposide—brain cancer	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Discomfort—Etoposide—brain cancer	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Feeling abnormal—Temozolomide—brain cancer	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Abdominal pain—Carmustine—brain cancer	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Body temperature increased—Carmustine—brain cancer	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Temozolomide—brain cancer	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Vomiting—Hydroxyurea—brain cancer	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Rash—Hydroxyurea—brain cancer	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Confusional state—Etoposide—brain cancer	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Dermatitis—Hydroxyurea—brain cancer	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Headache—Hydroxyurea—brain cancer	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Etoposide—brain cancer	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Urticaria—Temozolomide—brain cancer	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Abdominal pain—Temozolomide—brain cancer	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Body temperature increased—Temozolomide—brain cancer	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Etoposide—brain cancer	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Tachycardia—Etoposide—brain cancer	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Skin disorder—Etoposide—brain cancer	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Etoposide—brain cancer	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Anorexia—Etoposide—brain cancer	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Hypersensitivity—Carmustine—brain cancer	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Nausea—Hydroxyurea—brain cancer	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Hypotension—Etoposide—brain cancer	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Asthenia—Carmustine—brain cancer	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Hypersensitivity—Temozolomide—brain cancer	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Paraesthesia—Etoposide—brain cancer	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Asthenia—Temozolomide—brain cancer	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Dyspnoea—Etoposide—brain cancer	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Somnolence—Etoposide—brain cancer	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Diarrhoea—Carmustine—brain cancer	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Pruritus—Temozolomide—brain cancer	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Decreased appetite—Etoposide—brain cancer	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Etoposide—brain cancer	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Fatigue—Etoposide—brain cancer	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Dizziness—Carmustine—brain cancer	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Pain—Etoposide—brain cancer	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Constipation—Etoposide—brain cancer	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Diarrhoea—Temozolomide—brain cancer	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Dizziness—Temozolomide—brain cancer	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Feeling abnormal—Etoposide—brain cancer	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Vomiting—Carmustine—brain cancer	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Etoposide—brain cancer	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Rash—Carmustine—brain cancer	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Dermatitis—Carmustine—brain cancer	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Headache—Carmustine—brain cancer	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Vomiting—Temozolomide—brain cancer	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Urticaria—Etoposide—brain cancer	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Abdominal pain—Etoposide—brain cancer	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Body temperature increased—Etoposide—brain cancer	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Rash—Temozolomide—brain cancer	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Dermatitis—Temozolomide—brain cancer	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Headache—Temozolomide—brain cancer	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Nausea—Carmustine—brain cancer	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Nausea—Temozolomide—brain cancer	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Hypersensitivity—Etoposide—brain cancer	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Asthenia—Etoposide—brain cancer	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Pruritus—Etoposide—brain cancer	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Diarrhoea—Etoposide—brain cancer	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Dizziness—Etoposide—brain cancer	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Vomiting—Etoposide—brain cancer	0.000983	0.000983	CcSEcCtD
Gadoversetamide—Rash—Etoposide—brain cancer	0.000975	0.000975	CcSEcCtD
Gadoversetamide—Dermatitis—Etoposide—brain cancer	0.000974	0.000974	CcSEcCtD
Gadoversetamide—Headache—Etoposide—brain cancer	0.000969	0.000969	CcSEcCtD
Gadoversetamide—Nausea—Etoposide—brain cancer	0.000919	0.000919	CcSEcCtD
